检索
AI 对话
AI 辅写
analysis
趋势分析
编组
开放平台
more
更多
排名必读论文期刊顶会热点AI 简史溯源树小脉星探人才迁徙塔尖人才国防情报追踪开源工具智慧手语
VIPCreated with Sketch.

All Oral Fixed-dose Combination Sofosbuvir/Ledipasvir With or Without Ribavirin for 12 or 24 Weeks in Treatment-Naive Genotype 1 HCV-Infected Patients: The Phase 3 ION-1 Study

Ira M. Jacobson,Patrick Marcellin,Alessandra Mangia,Paul Y. Kwo,Graham Foster,Maria Buti,Norbert Brau,Andrew J. Muir,Jenny C. Yang,Hongmei Mo,Xiao Ding,Phil Pang,William T. Symonds,John G. McHutchison, Stefan Zeuzem,Nezam H. Afdhal

JOURNAL OF HEPATOLOGY（2014）

引用 3|浏览17
暂无评分
关键词
sofosbuvir/ledipasvir,ribavirin,fixed-dose,treatment-naive,hcv-infected
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要